Daly James M bought HALO
October 1, 2026 · Form 4 insider transaction
Daly James M bought 1,775 shares of Halozyme Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,775
Price
$0.00
Total value
N/A
InsiderDaly James M
RoleDirector
SecurityOption to Purchase Common Stock
Transaction codeA: Grant or award
Transaction dateOctober 1, 2026
Filing dateOctober 2, 2026
Shares owned after1,775
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents stock options granted under the Issuer's director compensation program. This grant will vest in full on the date of the Issuer's 2027 annual meeting of stockholders.